Formula & Concentration

von Willebrand Factor/Coagulation Factor VIII Complex (Human)

Manufacturer

Octapharma

Indications

WILATE is indicated in children and adults with von Willebrand disease for:

  • On-demand treatment and control of bleeding episodes
  • Perioperative management of bleeding

WILATE is not indicated for treatment of hemophilia A (1)

Product Options

Package Size

NDC #

Presentation

500 RCOF

68982-0182-01

Vial

1000 RCOF

68982-0182-02

Vial

Shelf Life and Storage

Store WILATE for up to 36 months at +2°C to +8°C (36°F to 46°F) in the original containers to protect from light from the date of manufacture. Within this period, WILATE may be stored for a period of up to 6 months at room temperature (maximum of +25°C or 77°F). The starting date of room temperature storage should be clearly recorded on the product carton. Once stored at room temperature, the product must not be returned to the refrigerator. The shelf-life then expires after the storage at room temperature, or the expiration date on the product vial, whichever is earliest. Do not freeze. Do not use after the expiration date. Reconstitute the WILATE powder only directly before injection. Use the solution immediately after reconstitution and discard any remaining solution.